
Overview
Spinaker Alfa Spółka Z Ograniczoną Odpowiedzialnoś is a fund that invests in early-stage research and development projects, providing up to 1 million PLN in capital along with strategic and operational support. The company focuses on innovative projects in industries such as FinTech, CleanTech, HealthTech, and ICT, emphasizing the commercialization of unique intellectual property. It supports projects that implement advanced technologies like blockchain, renewable energy solutions, health software, and various ICT tools.
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 96 days for 2021). All were audited by a statutory auditor.
- 2025not filed
- 202405/08/2025
- 202316/07/2024
- 202205/07/2023
- 202119/10/2022
- 202004/11/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Results vs industry
News
Industry
Offer
- Research and development project investments
- R&D project financing
- Strategic consulting
- Operational support
- Grant acquisition
Websites
The site is available in: Polish, English and German.
- spinakeralfa.plSPINAKER Alfa – wsparcie innowacyjnych projektów badawczo-rozwojowych na etapie pre-seed przez fundusze proof of concept – BRIdge AlfaWordPress 5.2Apache
General partners
Manner of representation
The company is represented by the general partner
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Inovatica Agv sp. z o.o. | 2,025.93 USD | 12% | ||
Cashy sp. z o.o. | 891.41 USD | 11.8705% | ||
Medifactory sp. z o.o. | 729.34 USD | 27% |
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Feb 11, 2021 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,294$1,294 | Prezydent Miasta Łódź |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Scanderia Venture sp. z o.o. | $198,970.37 | scanderiaventure.com | ||
| EVIG Alfa sp. z o.o. | $145,384.97 | evigalfa.pl | ||
| Polish Venture Fund sp. z o.o. + limited partnership | $88,022.16 | polishventurefund.pl | ||
| RDS Fund sp. z o.o. | $85,886.38 | rdsfund.com | ||
| Impera Alfa sp. z o.o. | $73,176.92 | imperaalfa.pl | ||
| Human Alfa sp. z o.o. | $46,255.68 | humanalfa.pl | ||
| Newberg Ml Spv sp. z o.o. | $30,740.64 | newberg.pl | ||
| Brave Seed Fund Fundusz Kapitałowy Warmii I Mazur sp. z o.o. + limited partnership | $19,985.46 | brave.vc | ||
| Terra Seed sp. z o.o. + limited partnership | $17,288.90 | terraseed.pl | ||
| Innovation Nest Gp Alternatywna Spółka Inwestycyjna Spółka Komandytowo – Akcyjna S.K.A. | $13,915.97 | innovationnest.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-03-06 | Address change (Ul. Wólczańska 125, 90-521, Łódź → Aleja T. Kościuszki 101, 90-441, Łódź) | |
| 2024-03-06 | Share capital increase (55,468.00 PLN → 55,948.00 PLN) | |
| 2023-07-18 | Share capital increase (52,720.00 PLN → 55,468.00 PLN) | |
| 2023-03-28 | Share capital increase (52,180.00 PLN → 52,720.00 PLN) | |
| 2022-10-05 | Share capital increase (51,656.00 PLN → 52,180.00 PLN) |
FAQ
Last updated: 2026-03-29





